Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.225 USD | +2.22% | -1.92% | +21.58% |
05-15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
05-09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.58% | 746M | |
+11.64% | 116B | |
+12.23% | 106B | |
-8.63% | 23.89B | |
-2.62% | 21.58B | |
-10.84% | 18.96B | |
-40.50% | 16.96B | |
-14.52% | 16.33B | |
+7.11% | 14.14B | |
+31.10% | 12.02B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024